..."And because these severely blocked areas are not in good locations, and there are also problems such as myocardial bridges, simply implanting stents can no longer solve the problem, so our plan is still to directly perform vascular implantation and bypass surgery to bypass the These severely blocked lesions will directly supply blood to the terminal blood vessels, which will completely solve the blockage problem in these locations.
As we all know, whether it is stent implantation or vascular implantation bypass surgery, it is the most conventional, safest and currently the best treatment option for the treatment of coronary heart disease and myocardial infarction. But they will also bring some problems, such as the need to take long-term medication after surgery, and long-term use of these drugs will cause some damage to the body, such as damage to liver and kidney function, and for example, long-term use of anticoagulant drugs will cause patients to of platelets decreased.
If the patient is injured in this way, it will cause excessive bleeding and the bleeding cannot be stopped in time, which may be life-threatening in severe cases.
Therefore, Mr. Zhang and his family still have some doubts about such a treatment plan. Coincidentally, we also learned that Haoyu Technology Company has been engaged in research in the field of medical technology and has developed many advanced medical technologies.
And there are experts from the Linghu Medical Research Center of the Affiliated Hospital of Air Force Medical College here. We also want to hear your opinions and suggestions. "
After listening to Director Bai's introduction, Director Tong nodded, and then said: "Your hospital's treatment work is very good. At this stage, it is most important to stabilize the patient's condition and maintain the patient's vital signs.
Judging from your introduction and the relevant inspection reports previously sent, the patient's condition is not optimistic. There are many areas of stenosis in the patient's heart, more than a dozen, of which five are the most serious, and two of them caused the myocardial infarction.
We agree with your opinion that stent implantation at this stage cannot completely solve these problems, and vascular implantation and bypass surgery are necessary.
Although the patient's cardiac myocardium was damaged and blood vessels were severely blocked, we still recommended that the patient undergo direct implantation of a smart bionic artificial heart until the last moment.
Although the success rate of smart bionic artificial heart implantation is very high, the patient's postoperative survival treatment is also very good. But this is a man-made thing after all, and is naturally not as good as our original hearts.
And some research shows that the human heart is also an emotional organ, which can reflect the patient's personality and emotions to a certain extent. For example, after the completion of many foreign allogeneic heart transplant surgeries, the patient's personality and even some behavioral habits have undergone great changes, and this change will be close to the donor's personality.
While there aren't enough case reports to confirm this finding, it is illustrative. Of course, the intelligent bionic artificial heart will not have emotions, but it may also destroy the patient's original emotional personality and behavioral habits to a certain extent.
And this is the last resort to save life. It is never the best choice unless it is a last resort. "
At this point, Director Tong paused, and then continued: "After relevant discussions, we have a total of three sets of treatment plans.
First of all, the first set of treatment plans is relatively conventional. The first is to use the latest biodegradable stents on the market in our country to implant and expand these cardiac stenoses, thereby leading to smooth blood flow in these locations.
The biggest advantage of this biodegradable stent compared to the original metal-coated stent is that it can be degraded and melted. It only needs to be implanted into the body, and after two or three years, these stents will completely degrade and integrate into the blood vessels, and form a stable support structure in the blood vessels to maintain the smooth flow of blood vessels.
Therefore, there will be no situation where the stent always remains in the blood vessel and is buried by vascular secretions for life and cannot be removed.
Based on this again, we will use bio-3D printing technology to extract the patient's blood vessel wall cells to print artificial blood vessels, and then use these artificial blood vessels to perform cardiac vascular implantation and bypass surgery for the patient.
And this time we are not answering one or two, but directly establishing a second blood supply channel for the patient's terminal myocardial tissue. In this way, we can increase the blood supply to the terminal myocardial tissue. Even if one blood vessel is narrowed and blocked, there will be another One blood vessel supplies blood, thereby avoiding the occurrence of myocardial infarction and angina pectoris.
In addition, using stem cell therapy, we will conduct stem cell treatment and repair of the patient's myocardial tissue damaged by infarction, thereby restoring the firepower of this part of the myocardial tissue and improving heart function. "
At this point, Director Tong glanced at the reactions of everyone in the video screen, and then continued: "This second set of treatment plans is also more thorough, that is, using bio-3D printing technology to print out the patient's blockage one by one. The coronary vascular tissue is then implanted and replaced, so that the patient has a new tubular arterial blood supply network.
Because the materials needed to print blood vessels are derived from the patient's own blood vessel wall cells, there will be no rejection reaction. The patient does not need to take medication for life, and the therapeutic effect is significant after treatment.
Of course, this treatment plan also requires the repair of the patient's damaged myocardial tissue, which can be repaired using stem cells or 3D bioprinting technology.
After treatment, the patient's life after recovery is still very good, and he can basically return to normal levels. "
"As for this third set of treatment options, it is more conservative. That is to use stents to implant and expand the blocked blood vessels in the patient's body to ensure the smooth flow of these blood vessels.
We have seen these two myocardial bridges, and bypass surgery is not necessarily necessary. This problem can be solved through the nanovascular stent developed by Haoyu Technology.
At the same time, on this basis, we can use biological stem cell tissue to repair the patient's damaged vascular tissue and myocardial tissue, thereby restoring heart function.
As for the problem of lifelong medication after surgery, there is a solution to this. The first is the reuse of biological agents. This kind of biological agent can replace drugs and play an anticoagulant role. In this way, it will not have too many toxic side effects and can be used for a long time.
The second method is also very simple. That is to implant micro-robots inside the patient's coronary arteries. The function of these micro-robots is to always decongest the vascular network, thereby ensuring the smooth flow of the vascular network. "
After listening to Director Tong's introduction, Director Bai, Vice President Huang and other doctors at the Mining Group General Hospital all showed expressions of amazement. These three plans are really eye-opening for them, and the benefits cost money.
(End of chapter)
